1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. AUTOIMMUNE DISEASE TESTING MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Instruments
5.2.1. Analyzers
5.2.2. Flow Crytometers
5.2.3. Others
5.3. Reagents & Consumables
6. AUTOIMMUNE DISEASE TESTING MARKET BY TEST TYPE
6.1. Introduction
6.2. Antinuclear Antibody (ANA) Test
6.3. C-Reactive Protein Test
6.4. Rheumatoid Factor
6.5. Anti-CCP Test
6.6. Others
7. AUTOIMMUNE DISEASE TESTING MARKET BY DISEASE TYPE
7.1. Introduction
7.2. Rheumatoid Arthritis
7.3. Lupus
7.4. Scleroderma
7.5. Vasculitis
7.6. Inflammatory Bowel Disease
7.7. Others
8. AUTOIMMUNE DISEASE TESTING MARKET BY END-USER
8.1. Introduction
8.2. Hospitals & Clinics
8.3. Diagnostic Centers
8.4. Others
9. AUTOIMMUNE DISEASE TESTING MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Spain
9.4.5. Italy
9.4.6. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Israel
9.5.4. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. F. Hoffmann-La Roche Ltd
11.2. Siemens Healthcare GmbH
11.3. Thermo Fisher Scientific Inc.
11.4. Quest Diagnostics Incorporated
11.5. Abbott
11.6. Werfen
11.7. Trinity Biotech Plc
11.8. Bio-Rad Laboratories, Inc.
11.9. Danaher Corporation
11.10. Exagen Inc
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES